Treatment of eosinophilic esophagitis (notice n° 175225)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01544cam a2200289 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112040115.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Zerbib, Frank |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Treatment of eosinophilic esophagitis |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 53 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The aim of treatment for eosinophilic esophagitis is to achieve both clinical and histological remission. It is assumed (though this has not been fully demonstrated) that histological remission may reduce the risk of the fibrotic evolution of the disease, that is, development of strictures and food impaction. International guidelines recommend three types of first-line treatment: proton pump inhibitors, topical steroids, and an elimination diet. The development of orodispersible budesonide tablets represents significant progress in the treatment of eosinophilic esophagitis. Esophageal dilation may be offered to patients with ongoing strictures despite therapy. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | dilation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | eosinophilic esophagitis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | proton pump inhibitors |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | elimination diet |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | topical steroids |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | dilation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | eosinophilic esophagitis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | proton pump inhibitors |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | elimination diet |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | topic steroids |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hagège, Hervé |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hépato-Gastro & Oncologie Digestive | 30 | 3 | 2023-03-02 | p. 359-363 | 2115-3310 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-hepato-gastro-et-oncologie-digestive-2023-3-page-359?lang=en">https://shs.cairn.info/journal-hepato-gastro-et-oncologie-digestive-2023-3-page-359?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux